Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: Clinical and prognostic significance
- 30 April 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 19 (5) , 953-959
- https://doi.org/10.1016/0735-1097(92)90277-t
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Frequency and importance of silent myocardial ischemia identified with ambulatory electrocardiographic monitoring in the early in-hospital period after acute myocardial infarctionThe American Journal of Cardiology, 1990
- “Silent ischemia”: What is it?Journal of the American College of Cardiology, 1989
- High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: Correlation with exercise testing and coronary angiographyJournal of the American College of Cardiology, 1989
- Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the coronary artery surgery study (CASS) registryThe American Journal of Cardiology, 1988
- Prognostic significance of ischemic episodes in patients with previous myocardial infarctionThe American Journal of Cardiology, 1988
- Silent ischemia predicts infarction and death during 2 year follow-up of unstable anginaJournal of the American College of Cardiology, 1987
- Prognostic significance of silent myocardial ischemia in patients with unstable anginaJournal of the American College of Cardiology, 1987
- Significance of silent myocardial ischemia during exercise testing in patients with coronary artery diseaseThe American Journal of Cardiology, 1987
- Role of dipyridamole-echocardiography test in electrocardiographically silent effort myocardial ischemiaThe American Journal of Cardiology, 1986
- Prognosis and treatment of asymptomatic coronary artery diseaseJournal of the American College of Cardiology, 1983